Role of MSH6 and PMS2 in the DNA Mismatch Repair Process and Carcinogenesis

Surgical Oncology Clinics of North America

Volumn 18, Issue 4, 2009, Pages 625-636

  Jenkins, Mark A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Mismatch repair; MSH6; Penetrance; PMS2

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

CANCER RISK; COLON CARCINOGENESIS; COLORECTAL CANCER; GENE DELETION; GENE DUPLICATION; GENE FUNCTION; GENE INSERTION; GENE MUTATION; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOTE DETECTION; HUMAN; LIFESTYLE; MISMATCH REPAIR; NONSENSE MUTATION; PENETRANCE; REVIEW;

ADENOSINE TRIPHOSPHATASES; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; HUMANS; NEOPLASMS;

EID: 70349305386     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2009.07.007     Document Type: Review

References (42)

1. Kunkel T.A., and Erie D.A. DNA mismatch repair. Annu Rev Biochem 74 (2005) 681-710
2. Schofield L., Watson N., Grieu F., et al. Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test. Int J Cancer 124 (2009) 1097-1102
3. Harfe B.D., and Jinks-Robertson S. DNA mismatch repair and genetic instability. Annu Rev Genet 34 (2000) 359-399
4. Miyaki M., Konishi M., Tanaka K., et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17 (1997) 271-272
5. Nicolaides N.C., Papadopoulos N., Liu B., et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371 (1994) 75-80
6. Woods M.O., Williams P., Careen A., et al. A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat 28 (2007) 669-673
7. Nicolaides N.C., Carter K.C., Shell B.K., et al. Genomic organization of the human PMS2 gene family. Genomics 30 (1995) 195-206
8. Nicolaides N.C., Kinzler K.W., and Vogelstein B. Analysis of the 5' region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene. Genomics 29 (1995) 329-334
9. Nakagawa H., Lockman J.C., Frankel W.L., et al. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res 64 (2004) 4721-4727
10. De Vos M., Hayward B.E., Picton S., et al. Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet 74 (2004) 954-964
11. Clendenning M., Hampel H., LaJeunesse J., et al. Long-range PCR facilitates the identification of PMS2-specific mutations. Hum Mutat 27 (2006) 490-495
12. Dunlop M.G., Farrington S.M., Nicholl I., et al. Population carrier frequency of hMSH2 and hMLH1 mutations. Br J Cancer 83 (2000) 1643-1645
13. Umar A., Boland C.R., Terdiman J.P., et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 (2004) 261-268
14. Jass J.R. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 12 (2006) 4943-4950
15. Hampel H., Frankel W.L., Martin E., et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26 (2008) 5783-5788
16. Hampel H., Stephens J.A., Pukkala E., et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 129 (2005) 415-421
17. Hampel H., Frankel W., Panescu J., et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66 (2006) 7810-7817
18. Goodfellow P.J., Buttin B.M., Herzog T.J., et al. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci U.S.A 100 (2003) 5908-5913
19. Barnetson R.A., Tenesa A., Farrington S.M., et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354 (2006) 2751-2763
20. Southey M.C., Jenkins M.A., Mead L., et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 23 (2005) 6524-6532
21. Vasen H.F., Watson P., Mecklin J.P., et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116 (1999) 1453-1456
22. Jenkins M.A., Dowty J.G., Hopper J.L., et al. Molecular screening of all colorectal tumors diagnosed before age 50 years followed by genetic testing efficiently identifies Lynch syndrome cases. Int J Cancer 124 (2009) x-xi
23. Hampel H., Frankel W.L., Martin E., et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352 (2005) 1851-1860
24. Mead L.J., Jenkins M.A., Young J., et al. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Clin Cancer Res 13 (2007) 2865-2869
25. Gill S., Lindor N.M., Burgart L.J., et al. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Clin Cancer Res 11 (2005) 6466-6471
26. Senter L., Clendenning M., Sotamaa K., et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135 (2008) 419-428
27. Easton D.F., Hopper J.L., Thomas D.C., et al. Breast cancer risks for BRCA1/2 carriers. Science 306 (2004) 2187-2191 [author reply-91]
28. Carayol J., Khlat M., Maccario J., et al. Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated. J Med Genet 39 (2002) 335-339
29. Hendriks Y.M., Wagner A., Morreau H., et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127 (2004) 17-25
30. Hendriks Y.M., Jagmohan-Changur S., van der Klift H.M., et al. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Gastroenterology 130 (2006) 312-322
31. Plaschke J., Engel C., Kruger S., et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22 (2004) 4486-4494
32. Cederquist K., Emanuelsson M., Goransson I., et al. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden. Int J Cancer 109 (2004) 370-376
33. Cederquist K., Emanuelsson M., Wiklund F., et al. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome. Clin Genet 68 (2005) 533-541
34. Buttin B.M., Powell M.A., Mutch D.G., et al. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet 74 (2004) 1262-1269
35. Jenkins M.A., Baglietto L., Dowty J.G., et al. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol 4 (2006) 489-498
36. Chen S., Wang W., Lee S., et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296 (2006) 1479-1487
37. Baglietto L., Lindor N., Dowty J., et al. Lynch syndrome cancer risks for MSH6 mutation carriers. J Natl Cancer Inst (2009) in press
38. De Vos M., Hayward B.E., Charlton R., et al. PMS2 mutations in childhood cancer. J Natl Cancer Inst 98 (2006) 358-361
39. Kruger S., Kinzel M., Walldorf C., et al. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. Eur J Hum Genet 16 (2008) 62-72
40. Poley J.W., Wagner A., Hoogmans M.M., et al. Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies. Cancer 109 (2007) 2349-2356
41. Will O., Carvajal-Carmona L.G., Gorman P., et al. Homozygous PMS2 deletion causes a severe colorectal cancer and multiple adenoma phenotype without extraintestinal cancer. Gastroenterology 132 (2007) 527-530
42. Worthley D.L., Walsh M.D., Barker M., et al. Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancer. Gastroenterology 128 (2005) 1431-1436